This is the authors' abstract. We don't add key points for this paper.
With the widespread application of nuclear technology in industrial production, medicine, and military fields, the risk of radiation exposure has significantly increased for both occupational workers and the general public. According to the UNSCEAR 2020/2021 Report, low-dose and low-dose-rate radiation for low-LET radiation (X-rays and γ-rays) is defined as a total dose of ≤100 mGy or a dose rate of ≤0.1 mGy/min. Low-dose radiation (LDR), is defined as ionizing radiation with a total dose below 100 mGy or a dose rate lower than 0.1 mGy/min, can lead to cumulative biological effects following prolonged or repeated exposure. This accumulation may result in varying degrees of damage to critical organ systems, including the cardiovascular, cerebrovascular, immune, and reproductive systems. Currently, most available radioprotective agents are designed for medium- and high-dose radiation scenarios, with limited research dedicated to preventive or protective strategies specifically targeting LDR. To address this gap, this review synthesizes recent scientific literature to systematically summarize the biological effects of LDR on human health and the latest advances in LDR-specific protective agents. These include low-molecule drugs, monomeric compounds derived from traditional Chinese medicine (TCM), bioactive TCM ingredients, and multi-component TCM formulations. The objective is to provide a scientific foundation for developing a comprehensive, precision-based radioprotection framework adaptable to diverse exposure conditions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: